Magnesium Sulfate Kalceks

Magnesium sulfate heptahydrate, the active ingredient in Magnesium Sulfate Kalceks, is a magnesium compound presented as an injection solution for intramuscular, intravenous, subcutaneous use. It treats magnesium deficiency and related conditions in patients such as those with hypomagnesemia, obstetric complications, and certain cardiac arrhythmias.

GNH USA supplies Magnesium Sulfate Kalceks as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Magnesium sulfate heptahydrate is used in magnesium replacement therapy to correct low serum magnesium levels and related disorders.

- Hypomagnesemia: restores normal serum magnesium concentrations and supports neuromuscular function. - Eclampsia and pre‑eclampsia: provides magnesium ions that prevent seizures and stabilize blood pressure in obstetric patients. - Torsades de pointes and other cardiac arrhythmias: helps normalize cardiac excitability and rhythm. - Severe asthma exacerbations: induces bronchodilation and reduces airway hyper‑responsiveness. - Magnesium deficiency in obstetric patients: corrects maternal magnesium loss and protects fetal health.

Adverse reactions may occur following administration of magnesium sulfate injection.

Common Side Effects: - Flushing or warmth at the injection site - Nausea or vomiting - Mild hypotension - Headache - Injection‑site pain or erythema - Sweating or feeling of warmth

Serious or Rare Side Effects: - Severe hypotension or cardiovascular collapse - Respiratory depression or arrest - Hypermagnesemia leading to muscle weakness or cardiac arrhythmia - Anaphylactic or severe allergic reaction - Cardiac arrest - Profound neuromuscular blockade

Magnesium sulfate should be used with careful clinical monitoring.

- Renal impairment: monitor serum magnesium and adjust dose. - Cardiac disease: observe ECG and blood pressure closely. - Pregnancy: evaluate risk‑benefit, especially in pre‑eclampsia. - Concomitant neuromuscular blocking agents: may potentiate blockade. - Calcium‑containing solutions: avoid simultaneous administration to prevent precipitation. - Store below 25°C: keep in original container, protect from moisture and light.

Magnesium sulfate can interact with several medicines; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Calcium‑containing solutions: risk of insoluble precipitate. - Neuromuscular blocking agents: enhanced muscle relaxation. - Potassium‑sparing diuretics: increased risk of hypermagnesemia.

Moderate Interactions (Monitor Closely): - ACE inhibitors: additive hypotensive effect. - Loop diuretics: may increase magnesium loss. - Aminoglycoside antibiotics: potential for increased neuromuscular blockade.